Literature DB >> 6716158

Outcome 1 year after SAH from cerebral aneurysm. Management morbidity, mortality, and functional status in 112 consecutive good-risk patients.

A H Ropper, N T Zervas.   

Abstract

A group of 112 consecutive patients who initially had no neurological deficits after subarachnoid hemorrhage (SAH) was followed intensively for at least 1 year. Ninety-four were in neurological Grade I or II (Hunt and Hess classification) on arrival. A hundred patients underwent late surgery but, despite excellent surgical results, major morbidity and mortality rates were observed related to preoperative complications. In the preoperative period, 14 (13%) rebled, 41 (37%) had symptomatic cerebral vasospasm, and 24 (21%) had hydrocephalus that required treatment. Of the 100 surgical patients, 73 were in Grade I or II, 26 in Grade III, and one in Grade IV. Six patients had intraoperative neurological complications, and two had delayed postoperative cerebral infarction. Six patients died during hospitalization, but only one as a result of operation. Six others died during the year following discharge of causes unrelated to the operation. The ultimate functional outcome at 1 year of these initially good-risk patients was poor. Only 46% were fully recovered, and 25% reported emotional or psychological disturbances that interfered with their daily lives. Forty-four percent could return to their previous jobs or a comparable position, and 20% obtained lesser employment. Management mortality at 1 year was 11%, and morbidity related to persistent neurological deficits (mainly strokes from vasospasm) was 20%. Thus, management mortality and morbidity at 1 year was 31%, and the number of patients returning to useful life was disappointing. The authors support the suggestion by previous workers that an analysis of at least the 6-month and perhaps the 1-year outcome (especially management mortality for all patients) provides the most important parameter for judging outcome and comparing different management protocols for SAH.

Entities:  

Mesh:

Year:  1984        PMID: 6716158     DOI: 10.3171/jns.1984.60.5.0909

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  37 in total

1.  Diversity in the Strength and Structure of Unruptured Cerebral Aneurysms.

Authors:  Anne M Robertson; Xinjie Duan; Khaled M Aziz; Michael R Hill; Simon C Watkins; Juan R Cebral
Journal:  Ann Biomed Eng       Date:  2015-01-30       Impact factor: 3.934

2.  Initial Clinical Experience with AView-A Clinical Computational Platform for Intracranial Aneurysm Morphology, Hemodynamics, and Treatment Management.

Authors:  Jianping Xiang; Nicole Varble; Jason M Davies; Ansaar T Rai; Kenichi Kono; Shin-Ichiro Sugiyama; Mandy J Binning; Rabih G Tawk; Hoon Choi; Andrew J Ringer; Kenneth V Snyder; Elad I Levy; L Nelson Hopkins; Adnan H Siddiqui; Hui Meng
Journal:  World Neurosurg       Date:  2017-09-15       Impact factor: 2.104

3.  Ruptured intracranial aneurysms. The influence of sex and fibromuscular dysplasia upon prognosis.

Authors:  B George; M Zerah; K L Mourier; F Gelbert; D Reizine
Journal:  Acta Neurochir (Wien)       Date:  1989       Impact factor: 2.216

Review 4.  Vascular smooth muscle cells in cerebral aneurysm pathogenesis.

Authors:  Robert M Starke; Nohra Chalouhi; Dale Ding; Daniel M S Raper; M Sean Mckisic; Gary K Owens; David M Hasan; Ricky Medel; Aaron S Dumont
Journal:  Transl Stroke Res       Date:  2013-10-10       Impact factor: 6.829

5.  Delayed cerebral ischaemia: the pathological substrate.

Authors:  G Neil-Dwyer; D A Lang; B Doshi; C J Gerber; P W Smith
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

Review 6.  Antifibrinolytic therapy to prevent early rebleeding after subarachnoid hemorrhage.

Authors:  Mark Chwajol; Robert M Starke; Grace H Kim; Stephan A Mayer; E Sander Connolly
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

7.  Differences in the management of ruptured intracranial aneurysms: a survey of practice amongst British neurosurgeons.

Authors:  H Marsh; R S Maurice-Williams; K W Lindsay
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-08       Impact factor: 10.154

8.  Intravascular balloon dilatation therapy for intracranial arterial vasospasm: patient selection, technique, and clinical results.

Authors:  R T Higashida; V V Halbach; C F Dowd; B Dormandy; J Bell; G B Hieshima
Journal:  Neurosurg Rev       Date:  1992       Impact factor: 3.042

9.  Shunt-dependent hydrocephalus after subarachnoid haemorrhage and aneurysm surgery: timing of surgery is not a risk factor.

Authors:  A Tapaninaho; J Hernesniemi; M Vapalahti; M Niskanen; A Kari; M Luukkonen; M Puranen
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

10.  Ruptured intracranial aneurysms: the overall effect of treatment and the influence of patient selection and data presentation on the reported outcome.

Authors:  R S Maurice-Williams; H Marsh
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.